who should not take glp-1 receptor agonists show promise in treating substance use disorders GLP-1 medications like Ozempic are

**Gastrointestinal Discomfort**: One of the most frequently reported side effects is gastrointestinal discomfort

In contrast, GHK-Cu treatment reversed these alterations

In a recent randomized Phase II trial, a broccoli sprout-derived SFN supplement given to former smokers for 12 months significantly decreased the Ki-67 proliferative index in their bronchial epithelium compared to an increase in the placebo group

Oxidized glutathione (GSSG) has already done its job

Without rigorous, peer-reviewed clinical trials, the long-term behaviour of these substances within the body remains less clear than that of MHRA-approved medications